GENinCode Plc (AIM:GENI)
London · Delayed Price · Currency is GBP · Price in GBX 0.9060
+0.0210 (2.37%)
Aug 17, 2026, 8:33 AM GMT
GENinCode Market Cap
GENinCode has a market cap or net worth of 6.66 million as of August 14, 2026. Its market cap has increased by 54.87% in one year.
Market Cap
6.66M
Enterprise Value
5.98M
Revenue
3.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.91
ChartMarket Cap Chart
Since July 22, 2021, GENinCode's market cap has decreased from 40.72M to 6.66M, a decrease of -83.63%. That is a compound annual growth rate of -30.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.66M | -3.21% |
| Dec 31, 2025 | 6.89M | 2.39% |
| Dec 31, 2024 | 6.72M | 33.68% |
| Dec 29, 2023 | 5.03M | -32.26% |
| Dec 30, 2022 | 7.43M | -76.15% |
| Dec 31, 2021 | 31.14M | -23.53% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Cizzle Biotechnology Holdings | 7.01M |
| Proteome Sciences | 6.33M |
| OptiBiotix Health | 5.94M |
| CRISM Therapeutics | 5.83M |